Michael Landsittel, CHIEF FINANCIAL OFFICER at Blueprint Medicines Corp (BPMC), sold 8,818 shares at $95.23 ($840K) on 2024-08-15, disclosed to the SEC on 2024-08-19.
Scheduled sale ($840k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.23 | 4,409 | $420K | 50.0% |
| 2 | $95.23 | 4,409 | $420K | 50.0% |
| Total | $95.23 avg | 8,818 | $840K | 100% |
| Filing → |
| BPMC | SELL | 2024-05-06 | $1.1M | — | Filing → |
| BPMC | SELL | 2024-04-01 | $475K | — | Filing → |
| BPMC | SELL | 2024-03-19 | $2.4M | — | Filing → |